Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,8.041917911227008e-43,126.86024096385542,12296.118054509543,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.7905455151957715e-40,0,0,69
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.153925249833429e-27,43.008225616921266,2603.289569700171,"['COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",8.942060308461e-25,0,0,48
3,Nonalcoholic fatty liver disease WP4396,2.4353862270507235e-18,12.734228971962617,516.4548189814088,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",2.81693006928867e-16,0,0,43
4,Oxidative phosphorylation WP623,1.021312732523243e-13,29.090389016018307,870.1667680921315,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5']",8.859887954639133e-12,0,0,25
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.9197010134705246e-12,69.46530147895335,1874.094064407224,"['NDUFA8', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",1.332272503348544e-10,0,0,20
6,Mitochondrial CIV Assembly WP4922,3.471607754361488e-11,62.37684449489217,1502.272583109646,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",2.0077464846057274e-09,0,0,18
7,Mitochondrial complex III assembly WP4921,6.984700702788481e-06,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0003462415919810861,0,0,8
8,Pyrimidine metabolism WP4022,0.00035721728561143994,5.151071025930102,40.88490744948014,"['NT5C', 'POLE4', 'POLD4', 'RRM2', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'NME1', 'POLR2L']",0.015494299763396207,0,0,12
9,Cellular Proteostasis WP4918,0.002661223353109549,inf,inf,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.10260494483655705,0,0,4
10,mRNA Processing WP411,0.006029856642873189,6.833146696528555,34.924431717130126,"['LSM7', 'SNRPD1', 'NCBP2', 'SNRPE', 'SRSF9', 'LSM2']",0.19021456864336334,0,0,6
11,Proteasome Degradation WP183,0.006029856642873189,6.833146696528555,34.924431717130126,"['PSMD8', 'PSMB6', 'PSMD7', 'H2AFZ', 'PSMB10', 'PSMB9']",0.19021456864336334,0,0,6
12,Dual hijack model of Vif in HIV infection WP3300,0.011732041729761682,inf,inf,"['ELOB', 'ELOC', 'RUNX1']",0.339251540018942,0,0,3
13,DNA Repair Pathways Full Network WP4946,0.014337660267240272,3.986547085201794,16.922356658118698,"['POLE4', 'POLD4', 'DCLRE1C', 'NEIL2', 'CENPX', 'APEX1', 'POLE3']",0.3827052394409519,0,0,7
14,Base Excision Repair WP4752,0.01811866816491845,5.6879194630872485,22.813178378597616,"['POLE4', 'POLD4', 'NEIL2', 'APEX1', 'POLE3']",0.4490841323733359,0,0,5
15,Modulators of TCR signaling and T cell activation WP5072,0.050433096194600804,2.6550822122571,7.931016384667008,"['ZAP70', 'FIBP', 'NDUFB10', 'TNFAIP3', 'RHOH', 'ELOB', 'RNF7']",0.9998487298732736,0,0,7
16,Amyotrophic lateral sclerosis (ALS) WP2447,0.051422101397887464,4.545251396648045,13.488884439038454,"['BAD', 'SLC1A2', 'BAX', 'NEFH']",0.9998487298732736,0,0,4
17,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.0516761869049697,inf,inf,"['ELOB', 'ELOC']",0.9998487298732736,0,0,2
18,"GPCRs, Class B Secretin-like WP334",0.08102104181862034,5.109375,12.840096360621693,"['ADGRE1', 'ADGRE2', 'GIPR']",0.9998487298732736,0,0,3
19,Nucleotide metabolism WP404,0.08102104181862034,5.109375,12.840096360621693,"['RRM2', 'NME2', 'OAZ1']",0.9998487298732736,0,0,3
20,Osteoclast Signaling WP12,0.08102104181862034,5.109375,12.840096360621693,"['AIMP2', 'ATP6V1G1', 'TNFRSF11B']",0.9998487298732736,0,0,3
21,Ferroptosis WP4313,0.08137291544042534,2.8411633109619685,7.127662752284297,"['MAP1LC3A', 'GPX4', 'FTH1', 'SAT2', 'FTL']",0.9998487298732736,0,0,5
22,Ciliary landscape WP4352,0.10860807003144721,1.7072072072072073,3.7900163286879773,"['PSMD8', 'PSMD7', 'EXOSC4', 'NDUFA5', 'SSNA1', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'DCAF11', 'LSM4']",0.9998487298732736,0,0,11
23,Non-small cell lung cancer WP4255,0.11431138343025977,2.434483860658357,5.279979490564917,"['BAD', 'GADD45A', 'CYCS', 'BAX', 'HRAS']",0.9998487298732736,0,0,5
24,Selenium Micronutrient Network WP15,0.12918250392912634,1.632442224833529,3.340840542181232,"['SELENOM', 'PRDX5', 'GPX4', 'ALOX5', 'ALOX5AP', 'SELENOW', 'TXN', 'F2', 'SELENOK', 'SEPHS2', 'SELENOH']",0.9998487298732736,0,0,11
25,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.13156453727879705,6.807134894091416,13.80662424018039,"['COX8A', 'COX5A']",0.9998487298732736,0,0,2
26,Biomarkers for pyrimidine metabolism disorders WP4584,0.13156453727879705,6.807134894091416,13.80662424018039,"['NT5C', 'RRM2']",0.9998487298732736,0,0,2
27,Fatty acid transporters WP5061,0.13156453727879705,6.807134894091416,13.80662424018039,"['FABP6', 'FABP7']",0.9998487298732736,0,0,2
28,Iron metabolism in placenta WP2007,0.13156453727879705,6.807134894091416,13.80662424018039,"['HEPHL1', 'FTH1']",0.9998487298732736,0,0,2
29,Peroxiredoxin 2 induced ovarian failure WP4873,0.13156453727879705,6.807134894091416,13.80662424018039,"['STAR', 'BAX']",0.9998487298732736,0,0,2
30,Pyrimidine metabolism and related diseases WP4225,0.13156453727879705,6.807134894091416,13.80662424018039,"['NT5C', 'RRM2']",0.9998487298732736,0,0,2
31,RalA downstream regulated genes WP2290,0.13156453727879705,6.807134894091416,13.80662424018039,"['RAC3', 'HRAS']",0.9998487298732736,0,0,2
32,DNA Mismatch Repair WP531,0.13523308788921182,3.4051339285714284,6.8128401375603875,"['POLE4', 'POLD4', 'POLE3']",0.9998487298732736,0,0,3
33,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.13523308788921182,3.4051339285714284,6.8128401375603875,"['XBP1', 'MAP1LC3A', 'DDIT3']",0.9998487298732736,0,0,3
34,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.13523308788921182,3.4051339285714284,6.8128401375603875,"['H3F3B', 'H2AFZ', 'HIST1H3E']",0.9998487298732736,0,0,3
35,Histone Modifications WP2369,0.13523308788921182,3.4051339285714284,6.8128401375603875,"['SET', 'H3F3B', 'HIST1H3E']",0.9998487298732736,0,0,3
36,Nanomaterial induced apoptosis WP2507,0.13523308788921182,3.4051339285714284,6.8128401375603875,"['ENDOG', 'BAX', 'CYCS']",0.9998487298732736,0,0,3
37,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.13523308788921182,3.4051339285714284,6.8128401375603875,"['ZAP70', 'HLA-DRB5', 'HLA-DRA']",0.9998487298732736,0,0,3
38,Photodynamic therapy-induced unfolded protein response WP3613,0.13523308788921182,3.4051339285714284,6.8128401375603875,"['NARS', 'XBP1', 'DDIT3']",0.9998487298732736,0,0,3
39,Computational Model of Aerobic Glycolysis WP4629,0.19809134321922228,2.553013392857143,4.133397678930549,"['TPI1', 'ALDOA', 'PFKM']",0.9998487298732736,0,0,3
40,Eukaryotic Transcription Initiation WP405,0.19809134321922228,2.553013392857143,4.133397678930549,"['POLR2I', 'POLR2J', 'POLR2K']",0.9998487298732736,0,0,3
41,Macrophage markers WP4146,0.19809134321922228,2.553013392857143,4.133397678930549,"['CD163', 'CD14', 'CD68']",0.9998487298732736,0,0,3
42,Nucleotide Excision Repair WP4753,0.19809134321922228,2.553013392857143,4.133397678930549,"['POLE4', 'POLD4', 'POLE3']",0.9998487298732736,0,0,3
43,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.22418451881185236,3.402452619843924,5.087639160855677,"['H3F3B', 'HIST1H3E']",0.9998487298732736,0,0,2
44,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.22418451881185236,3.402452619843924,5.087639160855677,"['BAD', 'BAX']",0.9998487298732736,0,0,2
45,Methionine De Novo and Salvage Pathway WP3580,0.22418451881185236,3.402452619843924,5.087639160855677,"['AHCY', 'TXN']",0.9998487298732736,0,0,2
46,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.22418451881185236,3.402452619843924,5.087639160855677,"['PTTG1', 'ANAPC11']",0.9998487298732736,0,0,2
47,Glycerolipids and Glycerophospholipids WP4722,0.2274219731388553,inf,inf,['CDIPT'],0.9998487298732736,0,0,1
48,Glycerophospholipid Biosynthetic Pathway WP2533,0.2274219731388553,inf,inf,['CDIPT'],0.9998487298732736,0,0,1
49,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.2274219731388553,inf,inf,['MAP1LC3A'],0.9998487298732736,0,0,1
50,Mitochondrial CII Assembly WP4920,0.2274219731388553,inf,inf,['SDHAF1'],0.9998487298732736,0,0,1
51,Nanoparticle triggered autophagic cell death WP2509,0.2274219731388553,inf,inf,['MAP1LC3A'],0.9998487298732736,0,0,1
52,Non-homologous end joining WP438,0.2274219731388553,inf,inf,['DCLRE1C'],0.9998487298732736,0,0,1
53,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.24133495777212038,1.7024608501118568,2.4201663244440446,"['BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX']",0.9998487298732736,0,0,5
54,Acute viral myocarditis WP4298,0.24982102257914027,1.5717116030665863,2.1799805391585174,"['ENDOG', 'ITGB2', 'RAC3', 'CYCS', 'BAX', 'AIF1']",0.9998487298732736,0,0,6
55,TP53 network WP1742,0.26611080868018744,2.0417410714285715,2.7029435695565613,"['SUMO1', 'GADD45A', 'BAX']",0.9998487298732736,0,0,3
56,IL1 and megakaryocytes in obesity WP2865,0.26611080868018744,2.0417410714285715,2.7029435695565613,"['TLR1', 'F2', 'S100A9']",0.9998487298732736,0,0,3
57,MET in type 1 papillary renal cell carcinoma WP4205,0.26611080868018744,2.0417410714285715,2.7029435695565613,"['BAD', 'RPL11', 'HRAS']",0.9998487298732736,0,0,3
58,Pancreatic adenocarcinoma pathway WP4263,0.2825185925542086,1.7016759776536312,2.150937011606735,"['BAD', 'GADD45A', 'RAC3', 'BAX']",0.9998487298732736,0,0,4
59,BDNF-TrkB Signaling WP3676,0.31962682201468334,2.2675585284280935,2.586379853677566,"['TRPC6', 'HRAS']",0.9998487298732736,0,0,2
60,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.31962682201468334,2.2675585284280935,2.586379853677566,"['HSD11B2', 'STAR']",0.9998487298732736,0,0,2
61,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.31962682201468334,2.2675585284280935,2.586379853677566,"['MAP1LC3A', 'FTL']",0.9998487298732736,0,0,2
62,Copper homeostasis WP3286,0.33620506239235953,1.7008928571428572,1.854031045391192,"['SCO2', 'COX17', 'ATOX1']",0.9998487298732736,0,0,3
63,IL-6 signaling pathway WP364,0.33620506239235953,1.7008928571428572,1.854031045391192,"['HCK', 'BAD', 'AGT']",0.9998487298732736,0,0,3
64,16p11.2 proximal deletion syndrome WP4949,0.3402996616490115,1.5121042830540037,1.6299405916196121,"['SPN', 'ALDOA', 'SEZ6L2', 'CDIPT']",0.9998487298732736,0,0,4
65,TNF-alpha signaling pathway WP231,0.38359563356877735,1.2757558790593504,1.222386314337664,"['BAD', 'TNFAIP3', 'BAX', 'CYBA', 'TXN', 'HRAS']",0.9998487298732736,0,0,6
66,Sleep regulation WP3591,0.3983520400436895,1.3604469273743016,1.2521813935413635,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9998487298732736,0,0,4
67,Genotoxicity pathway WP4286,0.3983520400436895,1.3604469273743016,1.2521813935413635,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9998487298732736,0,0,4
68,Melanoma WP4685,0.3983520400436895,1.3604469273743016,1.2521813935413635,"['BAD', 'GADD45A', 'BAX', 'HRAS']",0.9998487298732736,0,0,4
69,The alternative pathway of fetal androgen synthesis WP4524,0.40316761922873473,3.3997772828507795,3.0883674577698508,['STAR'],0.9998487298732736,0,0,1
70,Fatty acid beta-oxidation WP143,0.40316761922873473,3.3997772828507795,3.0883674577698508,['TPI1'],0.9998487298732736,0,0,1
71,Immune response to tuberculosis WP4197,0.40316761922873473,3.3997772828507795,3.0883674577698508,['IFIT3'],0.9998487298732736,0,0,1
72,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.40316761922873473,3.3997772828507795,3.0883674577698508,['AHCY'],0.9998487298732736,0,0,1
73,Nanoparticle triggered regulated necrosis WP2513,0.40316761922873473,3.3997772828507795,3.0883674577698508,['FTL'],0.9998487298732736,0,0,1
74,Nanoparticle-mediated activation of receptor signaling WP2643,0.40316761922873473,3.3997772828507795,3.0883674577698508,['HRAS'],0.9998487298732736,0,0,1
75,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.40316761922873473,3.3997772828507795,3.0883674577698508,['BAX'],0.9998487298732736,0,0,1
76,Serotonin and anxiety WP3947,0.41182365578750546,1.7001114827201784,1.508270973041923,"['POMC', 'CRH']",0.9998487298732736,0,0,2
77,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.41182365578750546,1.7001114827201784,1.508270973041923,"['STAR', 'HRAS']",0.9998487298732736,0,0,2
78,Monoamine Transport WP727,0.41182365578750546,1.7001114827201784,1.508270973041923,"['TNFRSF11B', 'AGT']",0.9998487298732736,0,0,2
79,p38 MAPK Signaling Pathway WP400,0.41182365578750546,1.7001114827201784,1.508270973041923,"['DDIT3', 'HRAS']",0.9998487298732736,0,0,2
80,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.41182365578750546,1.7001114827201784,1.508270973041923,"['BAD', 'HRAS']",0.9998487298732736,0,0,2
81,Endometrial cancer WP4155,0.4554491378900664,1.2363636363636363,0.9723644306442486,"['BAD', 'GADD45A', 'BAX', 'HRAS']",0.9998487298732736,0,0,4
82,IL-18 signaling pathway WP4754,0.4589897576055352,1.0669509026713744,0.8308638850328022,"['NRN1', 'IMP3', 'BAD', 'COX17', 'TNFAIP3', 'TNFRSF11B', 'NDUFC1', 'BPGM', 'RND2', 'GATA1', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'PTPN7', 'ITM2C']",0.9998487298732736,0,0,16
83,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.47312854435790413,1.2748325892857142,0.9540696201904536,"['TYROBP', 'ITGB2', 'CD14']",0.9998487298732736,0,0,3
84,Microglia Pathogen Phagocytosis Pathway WP3937,0.47396811478684536,1.1332586786114223,0.8461081866372282,"['HCK', 'TYROBP', 'NCF4', 'ITGB2', 'RAC3', 'CYBA']",0.9998487298732736,0,0,6
85,7q11.23 copy number variation syndrome WP4932,0.4904867141125754,1.133109619686801,0.8071786676601957,"['ATP5MC2', 'FZD9', 'ATP5MC3', 'ATP5F1E', 'ATP5MC1']",0.9998487298732736,0,0,5
86,Glycolysis and Gluconeogenesis WP534,0.4904867141125754,1.133109619686801,0.8071786676601957,"['LDHC', 'TPI1', 'SLC2A5', 'ALDOA', 'PFKM']",0.9998487298732736,0,0,5
87,Integrin-mediated Cell Adhesion WP185,0.4904867141125754,1.133109619686801,0.8071786676601957,"['SHC3', 'ITGB2', 'ITGA8', 'RAC3', 'HRAS']",0.9998487298732736,0,0,5
88,Transcriptional cascade regulating adipogenesis WP4211,0.49731653587915453,1.3596432552954292,0.9497496486327658,"['EGR2', 'DDIT3']",0.9998487298732736,0,0,2
89,Cori Cycle WP1946,0.49731653587915453,1.3596432552954292,0.9497496486327658,"['TPI1', 'ALDOA']",0.9998487298732736,0,0,2
90,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.49731653587915453,1.3596432552954292,0.9497496486327658,"['BANF1', 'HRAS']",0.9998487298732736,0,0,2
91,Fluoropyrimidine Activity WP1601,0.49731653587915453,1.3596432552954292,0.9497496486327658,"['RRM2', 'UPP2']",0.9998487298732736,0,0,2
92,Regulation of Actin Cytoskeleton WP51,0.5006118820837349,1.0815328169588259,0.7483386908417141,"['FGF17', 'GSN', 'TMSB4X', 'BRK1', 'RAC3', 'CD14', 'F2']",0.9998487298732736,0,0,7
93,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5105997416255756,1.1329608938547486,0.7615415085126548,"['SHC3', 'BAD', 'BAX', 'HRAS']",0.9998487298732736,0,0,4
94,Senescence and Autophagy in Cancer WP615,0.5177937961040683,1.0732598573701893,0.7063962335385376,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3A', 'GSN', 'HRAS', 'GABARAP']",0.9998487298732736,0,0,6
95,Cytosolic DNA-sensing pathway WP4655,0.5366651584635561,1.1328125,0.7050408859284851,"['RNF125', 'POLR2K', 'POLR2L']",0.9998487298732736,0,0,3
96,p53 transcriptional gene network WP4963,0.5366651584635561,1.1328125,0.7050408859284851,"['GADD45A', 'BAX', 'TNFRSF10D']",0.9998487298732736,0,0,3
97,Insulin Signaling WP481,0.5380982272532704,1.061940715883669,0.6580996954727182,"['XBP1', 'SHC3', 'RHOJ', 'HRAS', 'PFKM']",0.9998487298732736,0,0,5
98,Serotonin and anxiety-related events WP3944,0.5389690511946881,1.6993318485523385,1.0503521362229726,['CRH'],0.9998487298732736,0,0,1
99,Alanine and aspartate metabolism WP106,0.5389690511946881,1.6993318485523385,1.0503521362229726,['ASPA'],0.9998487298732736,0,0,1
100,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.5389690511946881,1.6993318485523385,1.0503521362229726,['IDH3B'],0.9998487298732736,0,0,1
101,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5389690511946881,1.6993318485523385,1.0503521362229726,['SST'],0.9998487298732736,0,0,1
102,Trans-sulfuration and one-carbon metabolism WP2525,0.5389690511946881,1.6993318485523385,1.0503521362229726,['AHCY'],0.9998487298732736,0,0,1
103,Trans-sulfuration pathway WP2333,0.5389690511946881,1.6993318485523385,1.0503521362229726,['AHCY'],0.9998487298732736,0,0,1
104,"COVID-19, thrombosis and anticoagulation WP4927",0.5389690511946881,1.6993318485523385,1.0503521362229726,['F2'],0.9998487298732736,0,0,1
105,Cysteine and methionine catabolism WP4504,0.5389690511946881,1.6993318485523385,1.0503521362229726,['AHCY'],0.9998487298732736,0,0,1
106,Ganglio Sphingolipid Metabolism WP1423,0.5389690511946881,1.6993318485523385,1.0503521362229726,['B4GALNT1'],0.9998487298732736,0,0,1
107,Glycosylation and related congenital defects WP4521,0.5389690511946881,1.6993318485523385,1.0503521362229726,['DPM3'],0.9998487298732736,0,0,1
108,HIF1A and PPARG regulation of glycolysis WP2456,0.5389690511946881,1.6993318485523385,1.0503521362229726,['TPI1'],0.9998487298732736,0,0,1
109,Homologous recombination WP186,0.5389690511946881,1.6993318485523385,1.0503521362229726,['POLD4'],0.9998487298732736,0,0,1
110,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.5389690511946881,1.6993318485523385,1.0503521362229726,['HRAS'],0.9998487298732736,0,0,1
111,Interleukin-11 Signaling Pathway WP2332,0.5389690511946881,1.6993318485523385,1.0503521362229726,['HRAS'],0.9998487298732736,0,0,1
112,Metabolism of alpha-linolenic acid WP4586,0.5389690511946881,1.6993318485523385,1.0503521362229726,['ALOX5'],0.9998487298732736,0,0,1
113,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5389690511946881,1.6993318485523385,1.0503521362229726,['B4GALNT1'],0.9998487298732736,0,0,1
114,MTHFR deficiency WP4288,0.5389690511946881,1.6993318485523385,1.0503521362229726,['CYCS'],0.9998487298732736,0,0,1
115,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.5389690511946881,1.6993318485523385,1.0503521362229726,['EIF1'],0.9998487298732736,0,0,1
116,Osteoblast Signaling WP322,0.5389690511946881,1.6993318485523385,1.0503521362229726,['TNFRSF11B'],0.9998487298732736,0,0,1
117,Purine metabolism and related disorders WP4224,0.5389690511946881,1.6993318485523385,1.0503521362229726,['APRT'],0.9998487298732736,0,0,1
118,Purine metabolism WP4792,0.5389690511946881,1.6993318485523385,1.0503521362229726,['APRT'],0.9998487298732736,0,0,1
119,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.5389690511946881,1.6993318485523385,1.0503521362229726,['AGT'],0.9998487298732736,0,0,1
120,Ras signaling WP4223,0.5595972865080184,1.0066093029055991,0.5843748359189039,"['ZAP70', 'GNG10', 'GNG3', 'SHC3', 'BAD', 'RAC3', 'RASAL3', 'HRAS']",0.9998487298732736,0,0,8
121,Androgen receptor signaling pathway WP138,0.5630467433349758,1.0454662655779974,0.6005081166353978,"['SUMO1', 'BAG1', 'DSTN', 'STUB1']",0.9998487298732736,0,0,4
122,Pathways in clear cell renal cell carcinoma WP4018,0.5630467433349758,1.0454662655779974,0.6005081166353978,"['LDHC', 'TPI1', 'ALDOA', 'PFKM']",0.9998487298732736,0,0,4
123,CAMKK2  Pathway WP4874,0.5743850588000853,1.1326644370122632,0.6280117701221,"['FIS1', 'MAP1LC3A']",0.9998487298732736,0,0,2
124,Cancer immunotherapy by PD-1 blockade WP4585,0.5743850588000853,1.1326644370122632,0.6280117701221,"['ZAP70', 'BATF']",0.9998487298732736,0,0,2
125,Type 2 papillary renal cell carcinoma WP4241,0.5743850588000853,1.1326644370122632,0.6280117701221,"['ELOB', 'ELOC']",0.9998487298732736,0,0,2
126,Unfolded protein response WP4925,0.5743850588000853,1.1326644370122632,0.6280117701221,"['XBP1', 'DDIT3']",0.9998487298732736,0,0,2
127,Vitamin D-sensitive calcium signaling in depression WP4698,0.5743850588000853,1.1326644370122632,0.6280117701221,"['GPX4', 'PVALB']",0.9998487298732736,0,0,2
128,DNA Replication WP466,0.5743850588000853,1.1326644370122632,0.6280117701221,"['POLD4', 'UBA52']",0.9998487298732736,0,0,2
129,Genes related to primary cilium development (based on CRISPR) WP4536,0.5743850588000853,1.1326644370122632,0.6280117701221,"['TMEM17', 'DYNLL1']",0.9998487298732736,0,0,2
130,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5743850588000853,1.1326644370122632,0.6280117701221,"['RNF125', 'PIN1']",0.9998487298732736,0,0,2
131,Regulation of Microtubule Cytoskeleton WP2038,0.5743850588000853,1.1326644370122632,0.6280117701221,"['PARD6A', 'F2RL2']",0.9998487298732736,0,0,2
132,IL-3 signaling pathway WP286,0.5955747661756887,1.0191964285714286,0.5281764795657385,"['HCK', 'BAD', 'HRAS']",0.9998487298732736,0,0,3
133,Oxidative Damage WP3941,0.5955747661756887,1.0191964285714286,0.5281764795657385,"['BAD', 'GADD45A', 'CYCS']",0.9998487298732736,0,0,3
134,DNA IR-double strand breaks and cellular response via ATM WP3959,0.6424364282050786,0.9705367096671444,0.42945027646125994,"['DCLRE1C', 'BAX']",0.9998487298732736,0,0,2
135,Eicosanoid Synthesis WP167,0.6424364282050786,0.9705367096671444,0.42945027646125994,"['ALOX5', 'ALOX5AP']",0.9998487298732736,0,0,2
136,Integrated Cancer Pathway WP1971,0.6424364282050786,0.9705367096671444,0.42945027646125994,"['BAD', 'BAX']",0.9998487298732736,0,0,2
137,Kit receptor signaling pathway WP304,0.6424364282050786,0.9705367096671444,0.42945027646125994,"['BAD', 'HRAS']",0.9998487298732736,0,0,2
138,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6424364282050786,0.9705367096671444,0.42945027646125994,"['BAD', 'CYCS']",0.9998487298732736,0,0,2
139,PPAR signaling pathway WP3942,0.6424364282050786,0.9705367096671444,0.42945027646125994,"['FABP6', 'FABP7']",0.9998487298732736,0,0,2
140,15q13.3 copy number variation syndrome WP4942,0.6438971290049721,1.1325167037861916,0.4985523166610555,['TRPM1'],0.9998487298732736,0,0,1
141,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6438971290049721,1.1325167037861916,0.4985523166610555,['HRAS'],0.9998487298732736,0,0,1
142,ACE Inhibitor Pathway WP554,0.6438971290049721,1.1325167037861916,0.4985523166610555,['AGT'],0.9998487298732736,0,0,1
143,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.6438971290049721,1.1325167037861916,0.4985523166610555,['DLL3'],0.9998487298732736,0,0,1
144,Sphingolipid pathway WP1422,0.6438971290049721,1.1325167037861916,0.4985523166610555,['ACER1'],0.9998487298732736,0,0,1
145,Transcription co-factors SKI and SKIL protein partners WP4533,0.6438971290049721,1.1325167037861916,0.4985523166610555,['MERTK'],0.9998487298732736,0,0,1
146,Type II diabetes mellitus WP1584,0.6438971290049721,1.1325167037861916,0.4985523166610555,['SURF1'],0.9998487298732736,0,0,1
147,Energy Metabolism WP1541,0.6438971290049721,1.1325167037861916,0.4985523166610555,['UCP3'],0.9998487298732736,0,0,1
148,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6438971290049721,1.1325167037861916,0.4985523166610555,['MAP1LC3A'],0.9998487298732736,0,0,1
149,Gastric acid production WP2596,0.6438971290049721,1.1325167037861916,0.4985523166610555,['CCK'],0.9998487298732736,0,0,1
150,Genes targeted by miRNAs in adipocytes WP1992,0.6438971290049721,1.1325167037861916,0.4985523166610555,['TMSB4X'],0.9998487298732736,0,0,1
151,Glutathione metabolism WP100,0.6438971290049721,1.1325167037861916,0.4985523166610555,['GPX4'],0.9998487298732736,0,0,1
152,Intraflagellar transport proteins binding to dynein WP4532,0.6438971290049721,1.1325167037861916,0.4985523166610555,['DYNLL1'],0.9998487298732736,0,0,1
153,LTF danger signal response pathway WP4478,0.6438971290049721,1.1325167037861916,0.4985523166610555,['CD14'],0.9998487298732736,0,0,1
154,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6438971290049721,1.1325167037861916,0.4985523166610555,['BAX'],0.9998487298732736,0,0,1
155,NOTCH1 regulation of endothelial cell calcification WP3413,0.6438971290049721,1.1325167037861916,0.4985523166610555,['DLL3'],0.9998487298732736,0,0,1
156,NRF2-ARE regulation WP4357,0.6438971290049721,1.1325167037861916,0.4985523166610555,['AIMP2'],0.9998487298732736,0,0,1
157,Overview of nanoparticle effects WP3287,0.6438971290049721,1.1325167037861916,0.4985523166610555,['BAX'],0.9998487298732736,0,0,1
158,PDGFR-beta pathway WP3972,0.6438971290049721,1.1325167037861916,0.4985523166610555,['HRAS'],0.9998487298732736,0,0,1
159,Phytochemical activity on NRF2 transcriptional activation WP3,0.6438971290049721,1.1325167037861916,0.4985523166610555,['AIMP2'],0.9998487298732736,0,0,1
160,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6493627371821201,0.9262378246753247,0.3999159641251681,"['APEX1', 'HRAS', 'MYL12B']",0.9998487298732736,0,0,3
161,Corticotropin-releasing hormone signaling pathway WP2355,0.6578665637899316,0.9054748603351955,0.3791704579924103,"['POMC', 'STAR', 'CRH', 'FOSB']",0.9998487298732736,0,0,4
162,Complement system WP2806,0.6607395342616493,0.9050505050505051,0.37504891521603395,"['FKBP2', 'FCGR3A', 'RPS19', 'ITGB2', 'F11', 'CD59', 'VSIG4', 'TXN']",0.9998487298732736,0,0,8
163,ErbB signaling pathway WP673,0.697841088823855,0.8487723214285714,0.3053576139017644,"['SHC3', 'BAD', 'HRAS']",0.9998487298732736,0,0,3
164,G Protein Signaling Pathways WP35,0.697841088823855,0.8487723214285714,0.3053576139017644,"['GNG10', 'GNG3', 'HRAS']",0.9998487298732736,0,0,3
165,Leptin signaling pathway WP2034,0.697841088823855,0.8487723214285714,0.3053576139017644,"['BAD', 'BAX', 'HRAS']",0.9998487298732736,0,0,3
166,Blood Clotting Cascade WP272,0.7015823556681168,0.8489409141583054,0.300879080891209,"['F11', 'F2']",0.9998487298732736,0,0,2
167,Translation Factors WP107,0.7015823556681168,0.8489409141583054,0.300879080891209,"['EEF1B2', 'EIF1']",0.9998487298732736,0,0,2
168,Development of ureteric collection system WP5053,0.7015823556681168,0.8489409141583054,0.300879080891209,"['ITGA8', 'PAX2']",0.9998487298732736,0,0,2
169,Notch Signaling WP268,0.7015823556681168,0.8489409141583054,0.300879080891209,"['DTX3L', 'DLL3']",0.9998487298732736,0,0,2
170,Chemokine signaling pathway WP3929,0.7087940863290518,0.8482642777155656,0.29196427086005367,"['CCR1', 'HCK', 'GNG10', 'GNG3', 'SHC3', 'HRAS']",0.9998487298732736,0,0,6
171,Apoptosis Modulation and Signaling WP1772,0.7142466947770738,0.8480941704035875,0.2854064727515045,"['ENDOG', 'BAD', 'CYCS', 'BAX', 'TNFRSF11B', 'TNFRSF10A', 'TNFRSF10D']",0.9998487298732736,0,0,7
172,Apoptosis Modulation by HSP70 WP384,0.7249646087978462,0.8491091314031181,0.2731010424134679,['CYCS'],0.9998487298732736,0,0,1
173,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7249646087978462,0.8491091314031181,0.2731010424134679,['CCK'],0.9998487298732736,0,0,1
174,Wnt signaling in kidney disease WP4150,0.7249646087978462,0.8491091314031181,0.2731010424134679,['FZD9'],0.9998487298732736,0,0,1
175,COVID-19 adverse outcome pathway WP4891,0.7249646087978462,0.8491091314031181,0.2731010424134679,['AGT'],0.9998487298732736,0,0,1
176,Galanin receptor pathway WP4970,0.7249646087978462,0.8491091314031181,0.2731010424134679,['POMC'],0.9998487298732736,0,0,1
177,ID signaling pathway WP53,0.7249646087978462,0.8491091314031181,0.2731010424134679,['PAX2'],0.9998487298732736,0,0,1
178,IL-7 signaling pathway WP205,0.7249646087978462,0.8491091314031181,0.2731010424134679,['BAD'],0.9998487298732736,0,0,1
179,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.7249646087978462,0.8491091314031181,0.2731010424134679,['BAX'],0.9998487298732736,0,0,1
180,MAPK Cascade WP422,0.7249646087978462,0.8491091314031181,0.2731010424134679,['HRAS'],0.9998487298732736,0,0,1
181,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7249646087978462,0.8491091314031181,0.2731010424134679,['SCO2'],0.9998487298732736,0,0,1
182,DNA damage response (only ATM dependent) WP710,0.7377380926121695,0.7984226092671706,0.2428533350738192,"['BAD', 'RAC3', 'BAX', 'HRAS']",0.9998487298732736,0,0,4
183,Proximal tubule transport WP4917,0.7377380926121695,0.7984226092671706,0.2428533350738192,"['ATP6V1G1', 'SLC7A9', 'ATP6V1E1', 'ATP6V1F']",0.9998487298732736,0,0,4
184,Integrated breast cancer pathway WP1984,0.737973370210348,0.8077660594439118,0.2454377290546957,"['GADD45A', 'BAD', 'BAX', 'PHB', 'FAU']",0.9998487298732736,0,0,5
185,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7410505799273547,0.7832245879120879,0.23472175479656346,"['TMSB4X', 'FZD9', 'NEFH']",0.9998487298732736,0,0,3
186,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7410505799273547,0.7832245879120879,0.23472175479656346,"['PSMD8', 'PSMD7', 'STUB1']",0.9998487298732736,0,0,3
187,3q29 copy number variation syndrome WP4906,0.7523498046022005,0.7543664065403196,0.21465790111951905,"['NCBP2', 'DYNLL1']",0.9998487298732736,0,0,2
188,Nephrotic syndrome WP4758,0.7523498046022005,0.7543664065403196,0.21465790111951905,"['TRPC6', 'PAX2']",0.9998487298732736,0,0,2
189,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7523498046022005,0.7543664065403196,0.21465790111951905,"['IGFBP2', 'BAX']",0.9998487298732736,0,0,2
190,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7523498046022005,0.7543664065403196,0.21465790111951905,"['STAR', 'AGT']",0.9998487298732736,0,0,2
191,Male infertility WP4673,0.7791942068878375,0.7270408163265306,0.18139302038645438,"['EPSTI1', 'HLA-DRA', 'PEX10']",0.9998487298732736,0,0,3
192,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7791942068878375,0.7270408163265306,0.18139302038645438,"['BAD', 'BAX', 'HRAS']",0.9998487298732736,0,0,3
193,Selective expression of chemokine receptors during T-cell polarization WP4494,0.7875927030930209,0.679064587973274,0.16214310170257623,['CCR1'],0.9998487298732736,0,0,1
194,7-oxo-C and 7beta-HC pathways WP5064,0.7875927030930209,0.679064587973274,0.16214310170257623,['HSD11B2'],0.9998487298732736,0,0,1
195,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7875927030930209,0.679064587973274,0.16214310170257623,['HRAS'],0.9998487298732736,0,0,1
196,Type II interferon signaling (IFNG) WP619,0.7875927030930209,0.679064587973274,0.16214310170257623,['PSMB9'],0.9998487298732736,0,0,1
197,ERK Pathway in Huntington's Disease WP3853,0.7875927030930209,0.679064587973274,0.16214310170257623,['HRAS'],0.9998487298732736,0,0,1
198,Ethanol effects on histone modifications WP3996,0.7875927030930209,0.679064587973274,0.16214310170257623,['AHCY'],0.9998487298732736,0,0,1
199,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7875927030930209,0.679064587973274,0.16214310170257623,['HRAS'],0.9998487298732736,0,0,1
200,Farnesoid X receptor pathway WP2879,0.7875927030930209,0.679064587973274,0.16214310170257623,['SLCO2B1'],0.9998487298732736,0,0,1
201,Gastric Cancer Network 2 WP2363,0.7875927030930209,0.679064587973274,0.16214310170257623,['S100A6'],0.9998487298732736,0,0,1
202,GDNF/RET signaling axis WP4830,0.7875927030930209,0.679064587973274,0.16214310170257623,['PAX2'],0.9998487298732736,0,0,1
203,IL17 signaling pathway WP2112,0.7875927030930209,0.679064587973274,0.16214310170257623,['IL17RB'],0.9998487298732736,0,0,1
204,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7875927030930209,0.679064587973274,0.16214310170257623,['SUPT4H1'],0.9998487298732736,0,0,1
205,Interferon type I signaling pathways WP585,0.7875927030930209,0.679064587973274,0.16214310170257623,['ZAP70'],0.9998487298732736,0,0,1
206,miRNA regulation of prostate cancer signaling pathways WP3981,0.7875927030930209,0.679064587973274,0.16214310170257623,['BAD'],0.9998487298732736,0,0,1
207,One-carbon metabolism and related pathways WP3940,0.7875927030930209,0.679064587973274,0.16214310170257623,['GPX4'],0.9998487298732736,0,0,1
208,One-carbon metabolism WP241,0.7875927030930209,0.679064587973274,0.16214310170257623,['AHCY'],0.9998487298732736,0,0,1
209,Parkinson's disease pathway WP2371,0.7875927030930209,0.679064587973274,0.16214310170257623,['CYCS'],0.9998487298732736,0,0,1
210,Prion disease pathway WP3995,0.7875927030930209,0.679064587973274,0.16214310170257623,['BATF'],0.9998487298732736,0,0,1
211,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7875927030930209,0.679064587973274,0.16214310170257623,['HRAS'],0.9998487298732736,0,0,1
212,Adipogenesis WP236,0.7951012324608784,0.7532661440836133,0.17271325758094272,"['GDF10', 'EGR2', 'GADD45A', 'DDIT3', 'MIF', 'AGT']",0.9998487298732736,0,0,6
213,Aryl Hydrocarbon Receptor Pathway WP2873,0.7954866673360989,0.6787068004459309,0.15528892458739388,"['AIP', 'BAX']",0.9998487298732736,0,0,2
214,Synaptic Vesicle Pathway WP2267,0.7954866673360989,0.6787068004459309,0.15528892458739388,"['SLC32A1', 'SLC17A6']",0.9998487298732736,0,0,2
215,Genes controlling nephrogenesis WP4823,0.7954866673360989,0.6787068004459309,0.15528892458739388,"['ITGA8', 'PAX2']",0.9998487298732736,0,0,2
216,Pathways affected in adenoid cystic carcinoma WP3651,0.7954866673360989,0.6787068004459309,0.15528892458739388,"['UHRF1', 'HRAS']",0.9998487298732736,0,0,2
217,Hepatitis B infection WP4666,0.7974951127818908,0.7370391985215446,0.1667769147683215,"['EGR2', 'BAD', 'CYCS', 'BAX', 'HRAS']",0.9998487298732736,0,0,5
218,TGF-beta Signaling Pathway WP366,0.8026473982944846,0.7139076742134667,0.15694529672771756,"['PARD6A', 'CITED1', 'SUMO1', 'FOSB']",0.9998487298732736,0,0,4
219,Hematopoietic Stem Cell Differentiation WP2849,0.8026473982944846,0.7139076742134667,0.15694529672771756,"['RHOH', 'FOSB', 'GATA1', 'RUNX1']",0.9998487298732736,0,0,4
220,Alzheimer's disease WP2059,0.8125827910335507,0.6783482142857142,0.14078267441902448,"['ATP5MD', 'BAD', 'CYCS']",0.9998487298732736,0,0,3
221,DNA damage response WP707,0.8125827910335507,0.6783482142857142,0.14078267441902448,"['GADD45A', 'CYCS', 'BAX']",0.9998487298732736,0,0,3
222,Folate Metabolism WP176,0.8125827910335507,0.6783482142857142,0.14078267441902448,"['AHCY', 'GPX4', 'F2']",0.9998487298732736,0,0,3
223,miRNA regulation of DNA damage response WP1530,0.8125827910335507,0.6783482142857142,0.14078267441902448,"['GADD45A', 'CYCS', 'BAX']",0.9998487298732736,0,0,3
224,NRF2 pathway WP2884,0.8170007807639776,0.7411014573991032,0.14978789038546958,"['SERPINA1', 'FTH1', 'TXN', 'SLC2A5', 'SLC5A3', 'FTL', 'CBR3']",0.9998487298732736,0,0,7
225,Ebola Virus Pathway on Host WP4217,0.8229941736277465,0.706096196868009,0.1375518871220645,"['HLA-DRB5', 'GSN', 'HLA-DRA', 'HLA-DOA', 'MERTK']",0.9998487298732736,0,0,5
226,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8318342181897049,0.6168034863687037,0.1135671624488185,"['SHC3', 'HRAS']",0.9998487298732736,0,0,2
227,Aryl Hydrocarbon Receptor Netpath WP2586,0.8318342181897049,0.6168034863687037,0.1135671624488185,"['AIP', 'HRAS']",0.9998487298732736,0,0,2
228,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8318342181897049,0.6168034863687037,0.1135671624488185,"['NDUFA13', 'ACAP1']",0.9998487298732736,0,0,2
229,Prolactin Signaling Pathway WP2037,0.8318342181897049,0.6168034863687037,0.1135671624488185,"['ZAP70', 'HRAS']",0.9998487298732736,0,0,2
230,MAPK Signaling Pathway WP382,0.8358283261610477,0.7321260654593988,0.13129365973361307,"['DUSP4', 'FGF17', 'GADD45A', 'DDIT3', 'RAC3', 'CD14', 'PTPN7', 'HRAS']",0.9998487298732736,0,0,8
231,Signaling of Hepatocyte Growth Factor Receptor WP313,0.835971968550665,0.5657015590200446,0.10135120270144969,['HRAS'],0.9998487298732736,0,0,1
232,ATM Signaling Network in Development and Disease  WP3878,0.835971968550665,0.5657015590200446,0.10135120270144969,['DCLRE1C'],0.9998487298732736,0,0,1
233,Cells and molecules involved in local acute inflammatory response  WP4493,0.835971968550665,0.5657015590200446,0.10135120270144969,['ITGB2'],0.9998487298732736,0,0,1
234,Cytokines and Inflammatory Response WP530,0.835971968550665,0.5657015590200446,0.10135120270144969,['HLA-DRA'],0.9998487298732736,0,0,1
235,Endothelin Pathways WP2197,0.835971968550665,0.5657015590200446,0.10135120270144969,['RIIAD1'],0.9998487298732736,0,0,1
236,GABA receptor Signaling WP4159,0.835971968550665,0.5657015590200446,0.10135120270144969,['SLC32A1'],0.9998487298732736,0,0,1
237,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.835971968550665,0.5657015590200446,0.10135120270144969,['DDIT3'],0.9998487298732736,0,0,1
238,Nephrogenesis WP5052,0.835971968550665,0.5657015590200446,0.10135120270144969,['PAX2'],0.9998487298732736,0,0,1
239,PDGF Pathway WP2526,0.835971968550665,0.5657015590200446,0.10135120270144969,['HRAS'],0.9998487298732736,0,0,1
240,Physiological and pathological hypertrophy of the heart WP1528,0.835971968550665,0.5657015590200446,0.10135120270144969,['AGT'],0.9998487298732736,0,0,1
241,SARS-CoV-2 mitochondrial interactions WP5038,0.835971968550665,0.5657015590200446,0.10135120270144969,['PHB'],0.9998487298732736,0,0,1
242,Breast cancer pathway WP4262,0.8376046363402616,0.718406033428455,0.12730807524849172,"['FGF17', 'SHC3', 'GADD45A', 'FZD9', 'BAX', 'HRAS', 'DLL3']",0.9998487298732736,0,0,7
243,Small cell lung cancer WP4658,0.8415920293588574,0.6357421875,0.1096400390804832,"['GADD45A', 'CYCS', 'BAX']",0.9998487298732736,0,0,3
244,EGF/EGFR signaling pathway WP437,0.8538788944820112,0.6454908220271349,0.10196554186396677,"['NDUFA13', 'FOSB', 'NEDD8', 'HRAS']",0.9998487298732736,0,0,4
245,VEGFA-VEGFR2 Signaling Pathway WP3888,0.8613706584424302,0.7852475064158531,0.11718277559551533,"['SET', 'SDF2L1', 'SSR4', 'ARPC5L', 'SARS', 'TXN', 'RPL10A', 'RPL7', 'RPL18A', 'TMSB4X', 'RHOJ', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'ATP6V1E1', 'ALDOA', 'TMSB10', 'HRAS']",0.9998487298732736,0,0,20
246,Pathogenic Escherichia coli infection WP2272,0.8622460637275489,0.5652173913043478,0.08377346520907317,"['ARPC5L', 'CD14']",0.9998487298732736,0,0,2
247,Prostaglandin Synthesis and Regulation WP98,0.8622460637275489,0.5652173913043478,0.08377346520907317,"['HSD11B2', 'S100A6']",0.9998487298732736,0,0,2
248,Alpha 6 Beta 4 signaling pathway WP244,0.8733414322122081,0.484727966910595,0.06564607715819562,['HRAS'],0.9998487298732736,0,0,1
249,Statin inhibition of cholesterol production WP430,0.8733414322122081,0.484727966910595,0.06564607715819562,['APOC1'],0.9998487298732736,0,0,1
250,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8733414322122081,0.484727966910595,0.06564607715819562,['ZAP70'],0.9998487298732736,0,0,1
251,Tumor suppressor activity of SMARCB1 WP4204,0.8733414322122081,0.484727966910595,0.06564607715819562,['H3F3B'],0.9998487298732736,0,0,1
252,IL-2 signaling pathway WP49,0.8733414322122081,0.484727966910595,0.06564607715819562,['HRAS'],0.9998487298732736,0,0,1
253,Joubert Syndrome WP4656,0.8733414322122081,0.484727966910595,0.06564607715819562,['TMEM17'],0.9998487298732736,0,0,1
254,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8733414322122081,0.484727966910595,0.06564607715819562,['HLA-DRA'],0.9998487298732736,0,0,1
255,RAS and bradykinin pathways in COVID-19 WP4969,0.8733414322122081,0.484727966910595,0.06564607715819562,['AGT'],0.9998487298732736,0,0,1
256,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8749525796752978,0.6159471813103098,0.08228166685418442,"['EGR2', 'SHC3', 'BAD', 'HRAS']",0.9998487298732736,0,0,4
257,TYROBP causal network in microglia WP3945,0.8842195284889843,0.6270196370867512,0.07715471102775522,"['TYROBP', 'ITGB2', 'CAPG', 'CYTL1', 'SLC1A5']",0.9998487298732736,0,0,5
258,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8875390691110211,0.5215676185575852,0.062224444459927496,"['BEX3', 'RNF7']",0.9998487298732736,0,0,2
259,White fat cell differentiation WP4149,0.8875390691110211,0.5215676185575852,0.062224444459927496,"['EGR2', 'DDIT3']",0.9998487298732736,0,0,2
260,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8875390691110211,0.5215676185575852,0.062224444459927496,"['TRPC6', 'PAX2']",0.9998487298732736,0,0,2
261,Apoptosis WP254,0.8881116005093457,0.5647321428571429,0.06700991185767281,"['BAD', 'CYCS', 'BAX']",0.9998487298732736,0,0,3
262,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8881116005093457,0.5647321428571429,0.06700991185767281,"['POMC', 'BAD', 'HRAS']",0.9998487298732736,0,0,3
263,ESC Pluripotency Pathways WP3931,0.8881116005093457,0.5647321428571429,0.06700991185767281,"['FGF17', 'FZD9', 'HRAS']",0.9998487298732736,0,0,3
264,Circadian rhythm related genes WP3594,0.8884835364911654,0.6578849028400597,0.07778775902086367,"['AHCY', 'STAR', 'CRH', 'AVP', 'RPS27A', 'UBA52', 'HCRTR1']",0.9998487298732736,0,0,7
265,Ciliopathies WP4803,0.8933456440270044,0.5889725528297304,0.06642533377919113,"['TMEM17', 'DNAAF3', 'CCNQ', 'CCDC28B']",0.9998487298732736,0,0,4
266,Vitamin D Receptor Pathway WP2877,0.895343745296873,0.6761797752808989,0.07475002528414475,"['LRRC25', 'COLEC11', 'GADD45A', 'ALOX5', 'S100A6', 'TNFAIP3', 'TNFRSF11B', 'CD14', 'S100A9']",0.9998487298732736,0,0,9
267,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.9022044644535531,0.4239977728285078,0.043635351572229725,['TLR1'],0.9998487298732736,0,0,1
268,Canonical and non-canonical Notch signaling WP3845,0.9022044644535531,0.4239977728285078,0.043635351572229725,['DLL3'],0.9998487298732736,0,0,1
269,Fas ligand pathway and stress induction of heat shock proteins WP314,0.9022044644535531,0.4239977728285078,0.043635351572229725,['CYCS'],0.9998487298732736,0,0,1
270,Inflammatory Response Pathway WP453,0.9022044644535531,0.4239977728285078,0.043635351572229725,['ZAP70'],0.9998487298732736,0,0,1
271,Ovarian infertility WP34,0.9022044644535531,0.4239977728285078,0.043635351572229725,['GJA4'],0.9998487298732736,0,0,1
272,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9022044644535531,0.4239977728285078,0.043635351572229725,['RAB13'],0.9998487298732736,0,0,1
273,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.9022044644535531,0.4239977728285078,0.043635351572229725,['BAX'],0.9998487298732736,0,0,1
274,T-cell receptor (TCR) signaling pathway WP69,0.9084659291100006,0.4841535276317885,0.046477719124415444,"['ZAP70', 'HRAS']",0.9998487298732736,0,0,2
275,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9084659291100006,0.4841535276317885,0.046477719124415444,"['IFI27L2', 'HRAS']",0.9998487298732736,0,0,2
276,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9084659291100006,0.4841535276317885,0.046477719124415444,"['CSF3R', 'F2RL2']",0.9998487298732736,0,0,2
277,22q11.2 copy number variation syndrome WP4657,0.90932068636698,0.5642458100558659,0.0536357716788768,"['RANBP1', 'MRPL40', 'THAP7', 'LRRC74B']",0.9998487298732736,0,0,4
278,Allograft Rejection WP2328,0.9220137632692784,0.5079241071428572,0.04124096284956714,"['HLA-DRB5', 'HLA-DRA', 'HLA-DOA']",0.9998487298732736,0,0,3
279,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9231328827056432,0.5414972067039107,0.043310076469376256,"['FZD9', 'WNT9A', 'HRAS', 'DLL3']",0.9998487298732736,0,0,4
280,ATM Signaling Pathway WP2516,0.9244957188586117,0.37676317743132887,0.029578493620527807,['GADD45A'],0.9998487298732736,0,0,1
281,Bladder cancer WP2828,0.9244957188586117,0.37676317743132887,0.029578493620527807,['HRAS'],0.9998487298732736,0,0,1
282,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9244957188586117,0.37676317743132887,0.029578493620527807,['HCK'],0.9998487298732736,0,0,1
283,Cardiac Progenitor Differentiation WP2406,0.9244957188586117,0.37676317743132887,0.029578493620527807,['MESP1'],0.9998487298732736,0,0,1
284,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.9244957188586117,0.37676317743132887,0.029578493620527807,['TNFRSF11B'],0.9998487298732736,0,0,1
285,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9244957188586117,0.37676317743132887,0.029578493620527807,['ALOX5'],0.9998487298732736,0,0,1
286,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9244957188586117,0.37676317743132887,0.029578493620527807,['RRM2'],0.9998487298732736,0,0,1
287,Metabolic reprogramming in colon cancer WP4290,0.9244957188586117,0.37676317743132887,0.029578493620527807,['SLC1A5'],0.9998487298732736,0,0,1
288,Neural Crest Cell Migration during Development WP4564,0.9244957188586117,0.37676317743132887,0.029578493620527807,['F2RL2'],0.9998487298732736,0,0,1
289,Neural Crest Cell Migration in Cancer WP4565,0.9244957188586117,0.37676317743132887,0.029578493620527807,['F2RL2'],0.9998487298732736,0,0,1
290,RANKL/RANK signaling pathway WP2018,0.9244957188586117,0.37676317743132887,0.029578493620527807,['TNFRSF11B'],0.9998487298732736,0,0,1
291,Focal Adhesion WP306,0.9252533906232164,0.60667471541911,0.04713112881440576,"['HCK', 'SHC3', 'BAD', 'ITGA8', 'RAC3', 'HRAS', 'MYL12B']",0.9998487298732736,0,0,7
292,Exercise-induced Circadian Regulation WP410,0.9257020928479568,0.4517279821627648,0.034874669616581984,"['SUMO1', 'UCP3']",0.9998487298732736,0,0,2
293,Pre-implantation embryo WP3527,0.9257020928479568,0.4517279821627648,0.034874669616581984,"['DDIT3', 'FOSB']",0.9998487298732736,0,0,2
294,Imatinib and Chronic Myeloid Leukemia WP3640,0.9417102220982468,0.33897550111358576,0.020358079320802507,['GADD45A'],0.9998487298732736,0,0,1
295,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.9417102220982468,0.33897550111358576,0.020358079320802507,['EGR2'],0.9998487298732736,0,0,1
296,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9417102220982468,0.33897550111358576,0.020358079320802507,['BAX'],0.9998487298732736,0,0,1
297,Cell cycle WP179,0.946264521752311,0.4614448051948052,0.025487039858450206,"['PTTG1', 'GADD45A', 'ANAPC11']",0.9998487298732736,0,0,3
298,Gastrin signaling pathway WP4659,0.946264521752311,0.4614448051948052,0.025487039858450206,"['CHGA', 'BAD', 'HRAS']",0.9998487298732736,0,0,3
299,Retinoblastoma gene in cancer WP2446,0.9514006915016991,0.3983212013902551,0.019844349570239783,"['RRM2', 'H2AFZ']",0.9998487298732736,0,0,2
300,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9550031875835233,0.30805831139906864,0.014183189714582538,['ZAP70'],0.9998487298732736,0,0,1
301,Head and Neck Squamous Cell Carcinoma WP4674,0.9550031875835233,0.30805831139906864,0.014183189714582538,['HRAS'],0.9998487298732736,0,0,1
302,IL-4 signaling pathway WP395,0.9550031875835233,0.30805831139906864,0.014183189714582538,['BAD'],0.9998487298732736,0,0,1
303,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9550031875835233,0.30805831139906864,0.014183189714582538,['ITGB2'],0.9998487298732736,0,0,1
304,MECP2 and Associated Rett Syndrome WP3584,0.9550031875835233,0.30805831139906864,0.014183189714582538,['SST'],0.9998487298732736,0,0,1
305,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9550031875835233,0.30805831139906864,0.014183189714582538,['AGT'],0.9998487298732736,0,0,1
306,Notch Signaling Pathway Netpath WP61,0.9550031875835233,0.30805831139906864,0.014183189714582538,['DLL3'],0.9998487298732736,0,0,1
307,Endoderm differentiation WP2853,0.963343527671904,0.42271205357142855,0.01578626797591977,"['DUSP4', 'TCEAL2', 'NME1']",0.9998487298732736,0,0,3
308,AGE/RAGE pathway WP2324,0.9652671868954261,0.28229398663697103,0.009979187943154388,['CYCS'],0.9998487298732736,0,0,1
309,Toll-like Receptor Signaling related to MyD88 WP3858,0.9652671868954261,0.28229398663697103,0.009979187943154388,['TLR1'],0.9998487298732736,0,0,1
310,Oncostatin M Signaling Pathway WP2374,0.9652671868954261,0.28229398663697103,0.009979187943154388,['HRAS'],0.9998487298732736,0,0,1
311,Thermogenesis WP4321,0.9731918107876797,0.2604934041459654,0.0070786693422798435,['HRAS'],0.9998487298732736,0,0,1
312,Glioblastoma signaling pathways WP2261,0.9731918107876797,0.2604934041459654,0.0070786693422798435,['HRAS'],0.9998487298732736,0,0,1
313,Peptide GPCRs WP24,0.9746758645302923,0.3382385730211817,0.008675924215597316,"['CCR1', 'HCRTR1']",0.9998487298732736,0,0,2
314,Osteoblast differentiation WP4787,0.9752138670415821,0.3899381868131868,0.009786856261141496,"['FZD9', 'WNT9A', 'DLL3']",0.9998487298732736,0,0,3
315,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9793097895861337,0.24180719058224626,0.005055523818469269,['ITGA8'],0.9998487298732736,0,0,1
316,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9793097895861337,0.24180719058224626,0.005055523818469269,['HRAS'],0.9998487298732736,0,0,1
317,TGF-beta Receptor Signaling WP560,0.9793097895861337,0.24180719058224626,0.005055523818469269,['HRAS'],0.9998487298732736,0,0,1
318,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9793097895861337,0.24180719058224626,0.005055523818469269,['TNFRSF11B'],0.9998487298732736,0,0,1
319,Prader-Willi and Angelman Syndrome WP3998,0.9793097895861337,0.24180719058224626,0.005055523818469269,['POMC'],0.9998487298732736,0,0,1
320,Spinal Cord Injury WP2431,0.9799271769099498,0.47048100210942995,0.009539952385533686,"['GADD45A', 'APEX1', 'TNFSF13', 'MIF', 'PDYN', 'AIF1']",0.9998487298732736,0,0,6
321,B Cell Receptor Signaling Pathway WP23,0.9837378274922877,0.30728691598256813,0.005038231074215909,"['PIK3AP1', 'HRAS']",0.9998487298732736,0,0,2
322,Toll-like Receptor Signaling Pathway WP75,0.9837378274922877,0.30728691598256813,0.005038231074215909,"['TLR1', 'CD14']",0.9998487298732736,0,0,2
323,Wnt signaling pathway and pluripotency WP399,0.9840326429795078,0.22561247216035635,0.0036315054418316743,['FZD9'],0.9998487298732736,0,0,1
324,G1 to S cell cycle control WP45,0.9840326429795078,0.22561247216035635,0.0036315054418316743,['GADD45A'],0.9998487298732736,0,0,1
325,Hippo-Merlin Signaling Dysregulation WP4541,0.9864155345094079,0.3492533866995074,0.004776940635464594,"['ITGB2', 'ITGA8', 'HRAS']",0.9998487298732736,0,0,3
326,Ectoderm Differentiation WP2858,0.9869963250433882,0.2938296737918666,0.0038459257038476954,"['TNFRSF11B', 'LY6E']",0.9998487298732736,0,0,2
327,Vitamin B12 metabolism WP1533,0.9876782352026005,0.21144209354120266,0.0026215240199635994,['F2'],0.9998487298732736,0,0,1
328,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9879498192040931,0.4961687235218272,0.006015238408640805,"['FGF17', 'PFKFB1', 'GNG10', 'GNG3', 'CSF3R', 'BAD', 'ITGB2', 'ITGA8', 'HRAS']",0.9998487298732736,0,0,9
329,Complement and Coagulation Cascades WP558,0.9896154675226766,0.2814938684503902,0.0029384660618872157,"['SERPINA1', 'F2']",0.9998487298732736,0,0,2
330,Glucocorticoid Receptor Pathway WP2880,0.9896154675226766,0.2814938684503902,0.0029384660618872157,"['ALOX5AP', 'TNFAIP3']",0.9998487298732736,0,0,2
331,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9904920709462379,0.19893881828900825,0.001900545683125638,['SLC38A2'],0.9998487298732736,0,0,1
332,Endochondral Ossification WP474,0.9904920709462379,0.19893881828900825,0.001900545683125638,['SLC38A2'],0.9998487298732736,0,0,1
333,Lung fibrosis WP3624,0.9904920709462379,0.19893881828900825,0.001900545683125638,['SERPINA1'],0.9998487298732736,0,0,1
334,Nuclear Receptors Meta-Pathway WP2882,0.992944204433683,0.509468696930344,0.003607448702472654,"['SERPINA1', 'FTH1', 'SLCO2B1', 'ALOX5AP', 'AIP', 'TNFAIP3', 'BAX', 'TXN', 'SLC2A5', 'SLC5A3', 'CBR3', 'FTL']",0.9998487298732736,0,0,12
335,Regulation of toll-like receptor signaling pathway WP1449,0.9940443237678361,0.3065137987012987,0.0018309546605185568,"['TLR1', 'TNFAIP3', 'CD14']",0.9998487298732736,0,0,3
336,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9943397021453548,0.1778806704958387,0.0010097179332335935,['FZD9'],0.9998487298732736,0,0,1
337,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9956329797650851,0.16893095768374164,0.0007393404454124978,['FZD9'],0.9998487298732736,0,0,1
338,Myometrial relaxation and contraction pathways WP289,0.9966916200768056,0.3205107741420591,0.0010621293444283897,"['GNG3', 'IGFBP2', 'CRH', 'IGFBP6']",0.9998487298732736,0,0,4
339,"GPCRs, Class A Rhodopsin-like WP455",0.9975690259483385,0.406489133761861,0.000989367587750696,"['CCR1', 'GPR65', 'OR7A5', 'APLNR', 'GPR37L1', 'OR7C1', 'F2RL2', 'HCRTR1']",0.9998487298732736,0,0,8
340,PI3K-Akt signaling pathway WP4172,0.9979478661898729,0.4002881216811565,0.0008222888004874473,"['FGF17', 'GNG10', 'GNG3', 'CSF3R', 'BAD', 'ITGA8', 'PIK3AP1', 'HRAS']",0.9998487298732736,0,0,8
341,Neural Crest Differentiation WP2064,0.997994812634493,0.14675123462767503,0.0002945591434798709,['DLL3'],0.9998487298732736,0,0,1
342,Wnt signaling WP428,0.9984530365365359,0.1405902004454343,0.00021765630002167926,['FZD9'],0.9998487298732736,0,0,1
343,"GPCRs, Other WP117",0.9988064946399343,0.13492204899777283,0.0001611263603951368,['ADGRE2'],0.9998487298732736,0,0,1
344,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9989220862286634,0.2460529181184669,0.00026536687593042445,"['SST', 'AVP', 'ALDOA']",0.9998487298732736,0,0,3
345,Mesodermal commitment pathway WP2857,0.9996729523843144,0.11224944320712694,3.671691718035878e-05,['RPL38'],0.9998487298732736,0,0,1
346,Calcium Regulation in the Cardiac Cell WP536,0.9996804927552825,0.17236943658348342,5.508208378737449e-05,"['GNG3', 'GJA4']",0.9998487298732736,0,0,2
347,Metapathway biotransformation Phase I and II WP702,0.9998487298732736,0.10194371330228791,1.5422204919058236e-05,['GPX4'],0.9998487298732736,0,0,1
